Estrogen receptor β promotes bladder cancer growth and invasion via alteration of miR-92a/DAB2IP signals

[1]  E. Messing,et al.  Recruited T cells promote the bladder cancer metastasis via up-regulation of the estrogen receptor β/IL-1/c-MET signals. , 2018, Cancer letters.

[2]  A. Jemal,et al.  Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.

[3]  Minfeng Chen,et al.  The Long Non-Coding RNA XIST Interacted with MiR-124 to Modulate Bladder Cancer Growth, Invasion and Migration by Targeting Androgen Receptor (AR) , 2017, Cellular Physiology and Biochemistry.

[4]  M. Fabbri,et al.  MicroRNAs in Oncogenesis and Tumor Suppression. , 2017, International review of cell and molecular biology.

[5]  J. Brugarolas,et al.  Loss of DAB2IP in RCC cells enhances their growth and resistance to mTOR-targeted therapies , 2016, Oncogene.

[6]  J. Gong,et al.  DAB2IP in cancer , 2015, Oncotarget.

[7]  S. Yeh,et al.  Recruited mast cells in the tumor microenvironment enhance bladder cancer metastasis via modulation of ERβ/CCL2/CCR2 EMT/MMP9 signals , 2015, Oncotarget.

[8]  Peng Guo,et al.  DAB2IP regulates the chemoresistance to pirarubicin and tumor recurrence of non-muscle invasive bladder cancer through STAT3/Twist1/P-glycoprotein signaling. , 2015, Cellular signalling.

[9]  Ying'ai Zhang,et al.  MicroRNA-24 upregulation inhibits proliferation, metastasis and induces apoptosis in bladder cancer cells by targeting CARMA3. , 2015, International journal of oncology.

[10]  Haiqiu Liao,et al.  microRNA-32 induces radioresistance by targeting DAB2IP and regulating autophagy in prostate cancer cells , 2015, Oncology letters.

[11]  S. Yeh,et al.  Tumor microenvironment B cells increase bladder cancer metastasis via modulation of the IL-8/androgen receptor (AR)/MMPs signals , 2015, Oncotarget.

[12]  Jer-Tsong Hsieh,et al.  The ATM inhibitor KU55933 sensitizes radioresistant bladder cancer cells with DAB2IP gene defect , 2015, International journal of radiation biology.

[13]  Athanasios Fevgas,et al.  DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions , 2014, Nucleic Acids Res..

[14]  E. Messing,et al.  Estrogen receptor alpha prevents bladder cancer via INPP4B inhibited akt pathway in vitro and in vivo. , 2014 .

[15]  Yi-jun Shen,et al.  Downregulation of DAB2IP results in cell proliferation and invasion and contributes to unfavorable outcomes in bladder cancer , 2014, Cancer science.

[16]  S. Yeh,et al.  Suppression of ERβ signaling via ERβ knockout or antagonist protects against bladder cancer development. , 2014, Carcinogenesis.

[17]  S. Yeh,et al.  The evolving understanding of microRNA in bladder cancer. , 2014, Urologic oncology.

[18]  A. Bode,et al.  Regulation of microRNAs by epigenetics and their interplay involved in cancer , 2013, Journal of experimental & clinical cancer research : CR.

[19]  W. Hung,et al.  STAT3 upregulates miR-92a to inhibit RECK expression and to promote invasiveness of lung cancer cells , 2013, British Journal of Cancer.

[20]  R. Chang,et al.  MicroRNA‐140‐5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma , 2013, Hepatology.

[21]  S. Yeh,et al.  Role of oestrogen receptors in bladder cancer development , 2013, Nature Reviews Urology.

[22]  N. Seki,et al.  Aberrant expression of microRNAs in bladder cancer , 2013, Nature Reviews Urology.

[23]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[24]  V. Beneš,et al.  Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer , 2012, Oncogene.

[25]  Wei Zhao,et al.  Low expression of DAB2IP contributes to malignant development and poor prognosis in hepatocellular carcinoma , 2012, Journal of gastroenterology and hepatology.

[26]  E. Messing,et al.  Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder , 2012, BJU international.

[27]  Y. Nagakawa,et al.  Deregulation of miR‐92a expression is implicated in hepatocellular carcinoma development , 2010, Pathology international.

[28]  Saiful Miah,et al.  Distinct microRNA alterations characterize high- and low-grade bladder cancer. , 2009, Cancer research.

[29]  D. Schilling,et al.  Economic aspects of bladder cancer: what are the benefits and costs? , 2009, World Journal of Urology.

[30]  P. Zamore,et al.  Small silencing RNAs: an expanding universe , 2009, Nature Reviews Genetics.

[31]  G. Sonpavde,et al.  Efficacy of selective estrogen receptor modulators in nude mice bearing human transitional cell carcinoma. , 2007, Urology.

[32]  J. Hsieh,et al.  Down-regulation of Human DAB2IP Gene Expression Mediated by Polycomb Ezh2 Complex and Histone Deacetylase in Prostate Cancer* , 2005, Journal of Biological Chemistry.

[33]  Hiroyuki Tagawa,et al.  Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. , 2004, Cancer research.

[34]  H. P. Robertson,et al.  The Expanding Universe , 1934, Science.